Grand Event Opens, Focusing on Cutting-Edge Technologies

In the golden autumn of October, Chongqing, a city nestled in the mountains, gathered with distinguished guests. From October 30th to November 2nd, the 22nd National Academic Meeting of Chinese Society of 0tolaryngology-Head and Neck Surgery was held. As an important series of events celebrating the 110th anniversary of the Chinese Medical Association, this conference brought together top experts from across the country to explore the latest breakthroughs in the field of otolaryngology-head and neck surgery. Nurotron shone brightly at the conference with its innovative technologies, becoming the focus of attention.

Authoritative Voice: Multiple Studies Confirm Nurotron’s Superior Product Performance

Channel Count Breakthrough: More Channels, Better Speech Perception

Prof. Jun LIU of the Henan Provincial People’s Hospital published “A Preliminary Study on the Impact of Activated Channel Count on Speech Perception in Modern Cochlear Implant Recipients,” directly addressing a core technical issue in cochlear implants: Does more channels necessarily mean better results?

The study compared the performance of 8, 12, 16, 22, and 24 channels, finding:

– Significant differences were found in MSP short sentence recognition scores between 8 and 22 channels, 8 and 24 channels, and 12 and 24 channels.

– Increasing the number of channels significantly improved speech recognition ability in quiet environments.

This conclusion points the way for the development of cochlear implant technology: more channels bring a better auditory experience!

Prof. Hao WU of the Shanghai Ninth People’s Hospital,Shanghai jiaoTong University School of Medicine, in his paper “Advances in Auditory Reconstruction for Sensorineural Hearing Loss,” specifically introduced the Nurotron Auditory Brainstem Implantation System—the first domestically produced auditory brainstem implantation system. This signifies a breakthrough for China in the cutting-edge field of auditory reconstruction, bringing hope to more complex cases!

Magnetic Resonance Compatibility: CS-30A Demonstrates Excellent Safety

Prof. Yuan LI from the Affiliated Hospital of Hangzhou Normal University shared a clinical study on the safety and efficacy of cochlear implants under magnetic resonance imaging in patients with severe to profound sensorineural ear disease, highlighting the clinical trial results of the Nurotron CS-30A cochlear implant:

– Small MRI artifact area and excellent compatibility

– Provides a safer and more convenient option for patients requiring frequent MRI examinations

The Nurotron Institute of Audiology, Speech and Medicine’s study on “Comparative Study of Speech Audiometry Results Between Direct Bluetooth Input and Sound Field Testing for Cochlear Implants” shows that in quiet environments, the speech recognition rate of cochlear implant users via Bluetooth direct input is significantly higher than that of sound field audiometry. Bluetooth audiometry is convenient to operate, reduces environmental interference, and provides a more accurate and efficient new approach for cochlear implant evaluation. The study on the reliability and validity of the “Quick Self-Assessment Questionnaire for Expected Cochlear Implant Use (QSACI)” in patients of different ages showed that QSACI scores were significantly correlated with patients’ postoperative hearing ability, demonstrating good reliability and validity. The QSACI can effectively help cochlear implant candidates and doctors conduct rapid assessments of expected outcomes and can be used for outcome evaluation and expectation management for implant recipients of different ages. Nurotron continuously strives to improve both product performance and user expectations.

Booth Highlights: Professional Recognition and Overwhelming Praise

During the conference, the Nurotron booth was bustling with visitors. Experts and physicians stopped to learn more about Nurotron’s cochlear implant products. Many clinicians expressed high praise for the product’s performance, and experts lauded its technological innovation and clinical effectiveness. The atmosphere was lively, with participants discussing the future development of hearing reconstruction technology.

Moving Forward with Determination: Nurotron Protects Hearing Health with Innovative Technology

At the CSOHNS 2025 conference, Nurotron, with its solid clinical data and superior product performance, once again demonstrated its technological strength and industry leadership in the field of auditory medicine.

From cochlear implants to auditory brainstem implant systems, Nurotron has always adhered to the philosophy of “innovation-led, quality-first,” continuously driving the development of auditory medical device technology in China.

In the future, Nurotron will continue to work hand in hand with medical professionals across the country, making unremitting efforts to help more hearing-impaired individuals regain their voices!

Nurotron, making technology humane, making sound heard!